Borderline resectable pancreatic cancer: a new classification for an old challenge.
Talamonti
Mark
M
D003131:Combined Modality Therapy; D006801:Humans; D008099:Liver / Q000098:blood supply; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D010179:Pancreas / Q000098:blood supply; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery*; D018579:Patient Selection; D014057:Tomography, X-Ray Computed